{"id":"https://openalex.org/W2755841503","doi":"https://doi.org/10.1177/2472630317729792","title":"Identification of Angiogenesis Inhibitors Using a Co-culture Cell Model in a High-Content and High-Throughput Screening Platform","display_name":"Identification of Angiogenesis Inhibitors Using a Co-culture Cell Model in a High-Content and High-Throughput Screening Platform","publication_year":2017,"publication_date":"2017-09-18","ids":{"openalex":"https://openalex.org/W2755841503","doi":"https://doi.org/10.1177/2472630317729792","mag":"2755841503","pmid":"https://pubmed.ncbi.nlm.nih.gov/28922619","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/6032403"},"language":"en","primary_location":{"id":"doi:10.1177/2472630317729792","doi":"https://doi.org/10.1177/2472630317729792","is_oa":true,"landing_page_url":"https://doi.org/10.1177/2472630317729792","pdf_url":"http://slas-technology.org/article/S2472630322012377/pdf","source":{"id":"https://openalex.org/S4387277866","display_name":"SLAS TECHNOLOGY","issn_l":"2472-6303","issn":["2472-6303","2472-6311"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-20","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"SLAS Technology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"http://slas-technology.org/article/S2472630322012377/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5088717910","display_name":"Shuaizhang Li","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210148682","display_name":"National Center for Advancing Translational Sciences","ror":"https://ror.org/04pw6fb54","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210148682"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shuaizhang Li","raw_affiliation_strings":["1 Division of Pre-Clinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD, USA","Division of Pre-Clinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1 Division of Pre-Clinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD, USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210148682"]},{"raw_affiliation_string":"Division of Pre-Clinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD, USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210148682"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112388980","display_name":"Chia-Wen Hsu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210148682","display_name":"National Center for Advancing Translational Sciences","ror":"https://ror.org/04pw6fb54","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210148682"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Chia-Wen Hsu","raw_affiliation_strings":["1 Division of Pre-Clinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD, USA","Division of Pre-Clinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1 Division of Pre-Clinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD, USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210148682"]},{"raw_affiliation_string":"Division of Pre-Clinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD, USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210148682"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066699283","display_name":"Srilatha Sakamuru","orcid":"https://orcid.org/0000-0002-9693-1832","observed_orcids":["https://orcid.org/0000-0002-9693-1832"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210148682","display_name":"National Center for Advancing Translational Sciences","ror":"https://ror.org/04pw6fb54","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210148682"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Srilatha Sakamuru","raw_affiliation_strings":["1 Division of Pre-Clinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD, USA","Division of Pre-Clinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1 Division of Pre-Clinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD, USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210148682"]},{"raw_affiliation_string":"Division of Pre-Clinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD, USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210148682"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113569228","display_name":"Chaozhong Zou","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I118047749","display_name":"American Type Culture Collection","ror":"https://ror.org/03thhhv76","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I118047749"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Chaozhong Zou","raw_affiliation_strings":["2 American Type Culture Collection, Gaithersburg, MD, USA","American Type Culture Collection, Gaithersburg, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2 American Type Culture Collection, Gaithersburg, MD, USA","institution_ids":["https://openalex.org/I118047749"]},{"raw_affiliation_string":"American Type Culture Collection, Gaithersburg, MD, USA","institution_ids":["https://openalex.org/I118047749"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011366541","display_name":"Ruili Huang","orcid":"https://orcid.org/0000-0001-8886-8311","observed_orcids":["https://orcid.org/0000-0001-8886-8311"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210148682","display_name":"National Center for Advancing Translational Sciences","ror":"https://ror.org/04pw6fb54","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210148682"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ruili Huang","raw_affiliation_strings":["1 Division of Pre-Clinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD, USA","Division of Pre-Clinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1 Division of Pre-Clinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD, USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210148682"]},{"raw_affiliation_string":"Division of Pre-Clinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD, USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210148682"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5038035464","display_name":"Menghang Xia","orcid":"https://orcid.org/0000-0001-7285-8469","observed_orcids":["https://orcid.org/0000-0001-7285-8469"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210148682","display_name":"National Center for Advancing Translational Sciences","ror":"https://ror.org/04pw6fb54","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210148682"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Menghang Xia","raw_affiliation_strings":["1 Division of Pre-Clinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD, USA","Division of Pre-Clinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1 Division of Pre-Clinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD, USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210148682"]},{"raw_affiliation_string":"Division of Pre-Clinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD, USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210148682"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5038035464"],"corresponding_institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210148682"],"apc_list":{"value":2070,"currency":"USD","value_usd":2070},"apc_paid":{"value":2070,"currency":"USD","value_usd":2070},"fwci":0.5845,"has_fulltext":true,"cited_by_count":17,"citation_normalized_percentile":{"value":0.62433656,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":97},"biblio":{"volume":"23","issue":"3","first_page":"217","last_page":"225"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/angiogenesis-inhibitors","display_name":"angiogenesis inhibitors","score":0.9940000176429749},{"id":"https://openalex.org/keywords/co-culture-assay","display_name":"co-culture assay","score":0.8360000252723694},{"id":"https://openalex.org/keywords/tube-formation","display_name":"tube formation","score":0.6549999713897705},{"id":"https://openalex.org/keywords/aortic-endothelial-cells","display_name":"aortic endothelial cells","score":0.9980000257492065},{"id":"https://openalex.org/keywords/topotecan","display_name":"topotecan","score":0.7680000066757202},{"id":"https://openalex.org/keywords/docetaxel","display_name":"docetaxel","score":0.9860000014305115},{"id":"https://openalex.org/keywords/bortezomib","display_name":"bortezomib","score":0.9980000257492065},{"id":"https://openalex.org/keywords/thimerosal","display_name":"thimerosal","score":0.9929999709129333},{"id":"https://openalex.org/keywords/hif-1alpha-pathway","display_name":"HIF-1\u03b1 pathway","score":0.9509999752044678},{"id":"https://openalex.org/keywords/nf-kappab-signaling","display_name":"NF-\u03baB signaling","score":0.9580000042915344},{"id":"https://openalex.org/keywords/tumor-angiogenesis","display_name":"tumor angiogenesis","score":0.5419999957084656}],"concepts":[{"id":"https://openalex.org/C2780394083","wikidata":"https://www.wikidata.org/wiki/Q539568","display_name":"Angiogenesis","level":2,"score":0.797281801700592},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.5555614233016968},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.47129547595977783},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.459998220205307},{"id":"https://openalex.org/C125593758","wikidata":"https://www.wikidata.org/wiki/Q15315135","display_name":"Telomerase reverse transcriptase","level":4,"score":0.4373142123222351},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.42926838994026184},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3666991591453552},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3485160768032074},{"id":"https://openalex.org/C94581717","wikidata":"https://www.wikidata.org/wiki/Q331839","display_name":"Telomerase","level":3,"score":0.17700892686843872},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.164260596036911},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.06274938583374023},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000069286","descriptor_name":"Bortezomib","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000077143","descriptor_name":"Docetaxel","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D002461","descriptor_name":"Cell Line, Transformed","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004353","descriptor_name":"Drug Evaluation, Preclinical","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D004730","descriptor_name":"Endothelium, Vascular","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D004730","descriptor_name":"Endothelium, Vascular","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009389","descriptor_name":"Neovascularization, Pathologic","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D015398","descriptor_name":"Signal Transduction","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016328","descriptor_name":"NF-kappa B","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D018920","descriptor_name":"Coculture Techniques","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019098","descriptor_name":"Telomerase","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D019772","descriptor_name":"Topotecan","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D020533","descriptor_name":"Angiogenesis Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D051795","descriptor_name":"Hypoxia-Inducible Factor 1, alpha Subunit","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D057166","descriptor_name":"High-Throughput Screening Assays","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D059630","descriptor_name":"Mesenchymal Stem Cells","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D059630","descriptor_name":"Mesenchymal Stem Cells","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.1177/2472630317729792","doi":"https://doi.org/10.1177/2472630317729792","is_oa":true,"landing_page_url":"https://doi.org/10.1177/2472630317729792","pdf_url":"http://slas-technology.org/article/S2472630322012377/pdf","source":{"id":"https://openalex.org/S4387277866","display_name":"SLAS TECHNOLOGY","issn_l":"2472-6303","issn":["2472-6303","2472-6311"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-20","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"SLAS Technology","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:4993041","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/6032403","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:6032403","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/6032403","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"SLAS Technol","raw_type":"Text"},{"id":"pmid:28922619","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/28922619","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"SLAS technology","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1177/2472630317729792","doi":"https://doi.org/10.1177/2472630317729792","is_oa":true,"landing_page_url":"https://doi.org/10.1177/2472630317729792","pdf_url":"http://slas-technology.org/article/S2472630322012377/pdf","source":{"id":"https://openalex.org/S4387277866","display_name":"SLAS TECHNOLOGY","issn_l":"2472-6303","issn":["2472-6303","2472-6311"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-20","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"SLAS Technology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9391000270843506,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320332163","display_name":"U.S. Food and Drug Administration","ror":"https://ror.org/034xvzb47"},{"id":"https://openalex.org/F4320337472","display_name":"National Center for Advancing Translational Sciences","ror":"https://ror.org/04pw6fb54"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2755841503.pdf","grobid_xml":"https://content.openalex.org/works/W2755841503.grobid-xml"},"referenced_works_count":57,"referenced_works":["https://openalex.org/W1516603921","https://openalex.org/W1551620887","https://openalex.org/W1561178184","https://openalex.org/W1868766650","https://openalex.org/W1965057088","https://openalex.org/W1977242675","https://openalex.org/W2012063336","https://openalex.org/W2013818100","https://openalex.org/W2014622549","https://openalex.org/W2025477257","https://openalex.org/W2039531162","https://openalex.org/W2041903098","https://openalex.org/W2043361109","https://openalex.org/W2052664016","https://openalex.org/W2056963648","https://openalex.org/W2062158131","https://openalex.org/W2073752235","https://openalex.org/W2074371917","https://openalex.org/W2081161751","https://openalex.org/W2084740377","https://openalex.org/W2085881821","https://openalex.org/W2086389105","https://openalex.org/W2089327501","https://openalex.org/W2094530193","https://openalex.org/W2094692526","https://openalex.org/W2101573301","https://openalex.org/W2108492672","https://openalex.org/W2115395371","https://openalex.org/W2117278013","https://openalex.org/W2117692326","https://openalex.org/W2121314018","https://openalex.org/W2122221458","https://openalex.org/W2125642455","https://openalex.org/W2126612804","https://openalex.org/W2127447993","https://openalex.org/W2128879247","https://openalex.org/W2130522035","https://openalex.org/W2135664375","https://openalex.org/W2141171507","https://openalex.org/W2152251876","https://openalex.org/W2156268819","https://openalex.org/W2157769714","https://openalex.org/W2158794607","https://openalex.org/W2159055057","https://openalex.org/W2159871322","https://openalex.org/W2162424705","https://openalex.org/W2165953450","https://openalex.org/W2166670383","https://openalex.org/W2166819037","https://openalex.org/W2278438433","https://openalex.org/W2315265027","https://openalex.org/W2343803828","https://openalex.org/W2409830322","https://openalex.org/W2415476865","https://openalex.org/W2580449060","https://openalex.org/W6639195840","https://openalex.org/W6715057006"],"related_works":["https://openalex.org/W2491380282","https://openalex.org/W2885370092","https://openalex.org/W2126612804","https://openalex.org/W2739728953","https://openalex.org/W44010592","https://openalex.org/W2602668770","https://openalex.org/W2074460421","https://openalex.org/W2891698411","https://openalex.org/W2602234521","https://openalex.org/W2141171507"],"abstract_inverted_index":{"Angiogenesis":[0],"is":[1],"an":[2,49],"important":[3],"hallmark":[4],"of":[5],"cancer,":[6],"contributing":[7],"to":[8,25,156],"tumor":[9],"formation":[10,20],"and":[11,42,73,132,147,164,187],"metastasis.":[12],"In":[13],"vitro":[14,32,51,97,190],"angiogenesis":[15,124,137],"models":[16,34],"for":[17,61,80,192],"analyzing":[18],"tube":[19],"serve":[21],"as":[22,129],"useful":[23],"tools":[24],"study":[26],"these":[27],"processes.":[28],"However,":[29],"current":[30],"in":[31,40,45,50,57,96,159,181,189],"co-culture":[33,52,98,172],"using":[35,64,94,176],"primary":[36],"cells":[37,72],"have":[38],"limitations":[39],"usefulness":[41],"consistency.":[43],"Therefore,":[44],"the":[46,95,101,150,160,165],"present":[47],"study,":[48,144],"assay":[53],"system":[54,191],"was":[55,92],"optimized":[56],"a":[58,185],"1536-well":[59],"format":[60],"high-throughput":[62],"screening":[63],"human":[65],"telomerase":[66],"reverse":[67],"transcriptase":[68],"(hTERT)\u2013immortalized":[69],"mesenchymal":[70],"stem":[71],"aortic":[74],"endothelial":[75],"cells.":[76],"The":[77,171],"National":[78],"Center":[79],"Advancing":[81],"Translational":[82],"Sciences":[83],"(NCATS)":[84],"Pharmaceutical":[85],"Collection":[86],"(NPC)":[87],"library":[88],"containing":[89],"2816":[90],"drugs":[91],"evaluated":[93],"assay.":[99],"From":[100],"screen,":[102],"35":[103],"potent":[104],"inhibitors":[105,116,125,138],"(IC":[106,117],"50":[107,118],"\u22641":[108],"\u00b5M)":[109],"were":[110,126,139,154],"identified,":[111,127],"followed":[112],"by":[113,175],"15":[114],"weaker":[115],"1\u201350":[119],"\u00b5M).":[120],"Moreover,":[121],"many":[122],"known":[123],"such":[128],"topotecan,":[130],"docetaxel,":[131],"bortezomib.":[133],"Several":[134],"potential":[135],"novel":[136],"also":[140],"identified":[141],"from":[142],"this":[143,182],"including":[145],"thimerosal":[146],"podofilox.":[148],"Among":[149],"inhibitors,":[151],"some":[152],"compounds":[153],"proved":[155],"be":[157],"involved":[158],"hypoxia-inducible":[161],"factor-1\u03b1":[162],"(HIF-1\u03b1)":[163],"nuclear":[166],"factor-kappa":[167],"B":[168],"(NF-\u03baB)":[169],"pathways.":[170],"model":[173],"developed":[174],"hTERT-immortalized":[177],"cell":[178],"lines":[179],"described":[180],"report":[183],"provides":[184],"consistent":[186],"robust":[188],"antiangiogenic":[193],"drug":[194],"screening.":[195]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2017-09-25T00:00:00"}